Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2012
05/16/2012EP2452997A2 Compound for an organic photoelectric element, and an organic photoelectric element comprising the same
05/16/2012EP2452937A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
05/16/2012EP2451802A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
05/16/2012EP2451801A1 Insecticidal compounds
05/16/2012EP2451800A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP2307383B1 Aminotetrahydroindazoloacetic acids
05/16/2012EP2305645B1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
05/16/2012EP2268628B1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
05/16/2012EP1851199B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
05/16/2012CN1931827B 2- and 2,5-substituted phenylketo-enols
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/16/2012CN102459236A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459235A 吡嗪基吡唑 Pyrazinyl pyrazole
05/16/2012CN102459234A 作为p70s6激酶抑制剂的取代的苯并三嗪类和喹喔啉类 As the substituted benzo triazines and quinoxaline p70s6 kinase inhibitor
05/16/2012CN102459233A 二取代的酞嗪hedgehog途径拮抗剂 Disubstituted phthalazine hedgehog pathway antagonists
05/16/2012CN102459232A 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
05/16/2012CN102459231A 季铵盐化合物 Quaternary ammonium compounds
05/16/2012CN102459230A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459229A 用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷 Orexin antagonists used azabicyclo [4.1.0] heptane
05/16/2012CN102459228A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459227A Ccr2的4-氮杂环丁烷基-1-苯基-环己烷拮抗剂 Ccr2 4-azetidinyl-1-phenyl - cyclohexane antagonist
05/16/2012CN102459226A Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroatom attached - cyclohexane antagonist
05/16/2012CN102459225A Ccr2的4-氮杂环丁烷基-1-杂芳基-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroaryl - cyclohexane antagonist
05/16/2012CN102459224A 5-alkynyl-pyridines
05/16/2012CN102459223A 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
05/16/2012CN102459222A 用作gpr119 调节剂的l-(哌啶-4-基)-吡唑衍生物 Used gpr119 modulators l- (piperidin-4-yl) - pyrazole derivatives
05/16/2012CN102459192A 制备用作TAFIa抑制剂的化合物的方法 TAFIa inhibitor used in the preparation method of the compound
05/16/2012CN102459189A 5-元杂环化合物环戊二烯并[c]吡咯基烷基氨基甲酸酯衍生物、其制备、及其治疗用途 5-membered heterocyclic compound cyclopenta [c] pyrrolyl group carbamate derivatives, their preparation, and their therapeutic use
05/16/2012CN102459187A Janus激酶抑制化合物和方法 Janus kinase inhibiting compounds and methods
05/16/2012CN102459186A 抗蠕虫剂和其应用 Anthelmintics and their applications
05/16/2012CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists
05/16/2012CN102459183A Inhibitors of human immunodeficiency virus replication
05/16/2012CN102459179A Pyridinone antagonists of alpha-4 integrins
05/16/2012CN102459175A 用于治疗糖尿病的哌啶衍生物 For treating diabetes piperidine derivative
05/16/2012CN102459174A 4-(3-氯-2-氟苯胺基)-7-甲氧基-6-[1-(n-甲基氨基甲酰基甲基)哌啶-4-基]喹唑啉的制备方法 4- (3-chloro-2-fluoroanilino) -7-methoxy -6- [1- (n- methyl-carbamoylmethyl) piperidin-4-yl] quinazoline preparation
05/16/2012CN102459172A 四环化合物 Tetracyclic compounds
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459166A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459165A 抗病毒化合物 Antiviral compounds
05/16/2012CN102458402A Nicotinamide compounds useful as kinase modulators
05/16/2012CN102453024A Nilotinib hydrochloride crystalline form and preparation method thereof
05/16/2012CN102453023A Process for producing azelnidipine
05/16/2012CN102453022A Method for preparing imazethapyr
05/16/2012CN102453021A Novel crystal form of lenalidomide and preparation method thereof
05/16/2012CN102453020A Novel crystal form of lenalidomide and preparation method thereof
05/16/2012CN102452988A Quinazoline derivative and preparation method thereof
05/16/2012CN102452974A Organic light-emitting device
05/16/2012CN101253164B Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178692 Methods for production of 1,2,4-triazol-3-one
05/15/2012US8178691 Methods for production of 1,2,4-triazol-3-one
05/15/2012US8178678 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
05/15/2012US8178672 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
05/15/2012US8178668 2-aminopyridine kinase inhibitors
05/15/2012US8178667 Benzyl-substituted quinolone M1 receptor positive allosteric modulators
05/15/2012US8178570 Tie-2 modulators and methods of use
05/15/2012US8178560 Therapeutic agents useful for treating pain
05/15/2012US8178559 Organic compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178553 Compounds for the treatment of inflammatory disorders
05/15/2012US8178548 Anti-infective agents and uses thereof
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012US8178531 Antiviral agents
05/15/2012US8178517 6-methylvitamin D3 analogs and their uses
05/15/2012US8178513 Heterocyclic aspartyl protease inhibitors
05/15/2012US8178215 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound
05/15/2012CA2694480C Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
05/15/2012CA2603706C Photochromic indeno-fused naphthopyrans having extended pi-conjugated systems, compositions and articles including the same
05/15/2012CA2597632C Substituted sulfoxide compounds, methods for preparing the same and use thereof
05/15/2012CA2572631C A crystalline variable hydrate of (s)-(3-pyridinecarboxamide,6-[4-[2-[[3-(9h-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy]- hemi-succinate salt
05/15/2012CA2546781C Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
05/15/2012CA2526361C Amide derivative
05/15/2012CA2517361C Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/15/2012CA2464471C Method of treating depression with delta receptor agonist compounds
05/15/2012CA2430978C Vla-4 inhibitors
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/10/2012WO2012061708A1 Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors
05/10/2012WO2012061696A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
05/10/2012WO2012061602A1 Isoindolinone kinase inhibitors
05/10/2012WO2012061428A2 Nicotinamides as jak kinase modulators
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061337A1 Fgfr2 modulators
05/10/2012WO2012061290A2 Pesticidal compositions and processes related thereto
05/10/2012WO2012061169A1 Benzimidazole inhibitors of leukotriene production
05/10/2012WO2012060317A1 Ectoparasite control agent for animals
05/10/2012WO2012060308A1 Medicine for preventing and treating renal dysfunction
05/10/2012WO2012059932A1 2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
05/10/2012WO2012059869A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
05/10/2012WO2012059507A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012WO2012059497A1 N-hetarylmethyl pyrazolylcarboxamides
05/10/2012WO2012059442A2 Neurotrypsin inhibitors
05/10/2012WO2012059050A1 Substituted biaryl benzenesulfonamide compound and use
05/10/2012WO2012059048A1 Pyrazole amide compound and use thereof
05/10/2012WO2012059001A1 Imidazole derivatives and preparation method and use thereof
05/10/2012US20120116287 Photolabile compounds
05/10/2012US20120116089 Benzimidazole derivative
05/10/2012US20120116088 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
05/10/2012US20120116081 Process for the Synthesis of 5-(Methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine
05/10/2012US20120116080 Process for the stereoselective preparation of bicyclic heterocycles
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 1080